Why real-world data is helping us overcome the shortcomings of traditional clinical trials

Karen Ooms at Quanticate explains why clinical trial data alone is not enough to truly understand a drug’s effectiveness and argues that real-world data (RWD) is the key to filling the gap. Randomized clinical trials have long been a central feature of the drug development process, giving us valuable information about the performance and safety of drug candidates.

Read the source article at World Pharma Today
2021-09-13 17:17:01